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Approximately 70% of Americans are overweight or obese and studies have shown that 
poverty-dense American counties are the most prone to obesity (Levine, 2011). Along with diet, 
the endogenous circadian rhythms have been found to be an important piece of human 
metabolic health. Circadian disruption in humans, such as jet-lag and shift work, have been linked 
to metabolic problems such as Type 2 Diabetes Mellitus and Metabolic Syndrome. Since circadian 
disruption affects many demographics including shift workers and routine business travelers it is 
imperative to understand the biological mechanism behind the relationship between circadian 
disruption and weight gain. One potential connection between circadian function and eating 
behaviors is the Neuropeptide Y (NPY)/Peptide YY (PYY) system which causes satiety after food 
intake. This study conducted three experiments (i) in a 12:12 light dark cycle (LD) were assigned 
to four temporal sac groups (ZT 0, ZT 6, ZT 12, or ZT 18)  (ii) in a LD mice were assigned to four 
temporal injection groups (ZT 0, ZT 6, ZT 12, or ZT 18) and paired with either a PYY3-36 or vehicle 
(control) (iii) mice were exposed to LD or constant light (LL) paired with either a PYY3-36 or vehicle 
(control) injection during the onset of their active period, ZT 12. In the first experiment, it was 
found that PYY3-36 is regulated cyclically. In the second experiment, PYY3-36 reduced food intake, 
being most effective during the beginning of the night. PYY3-36 injections were also found to be 
effective in inhibiting food intake regardless of the light cycle. This suggests that photic cues are 







Circadian rhythms are endogenous cycles within organisms approximately 24 hours in 
length which is controlled by a transcriptional-translational feedback loop in mammals. 
Transcriptional activators CLOCK/BMAL1 upregulate PER1-3/CRY1-2 which throughout the day 
acquire post-translational modifications which accumulate, localize to the nucleus and inhibit its 
activators (Huang et al., 2011). This feedback loop occurs within the hypothalamus in a region 
known as the superchiasmatic nuclei (SCN) which is the master regulator of circadian rhythms 
within mammals (Fonken and Nelson 2014). Peripheral tissues are then synced to the SCN via 
neural and hormonal signals; these peripheral tissues also containing core molecular clock 
mechanisms (Huang et al., 2011). Without the presence of external time cues, referred to as 
zeitgebers or “time givers”, circadian rhythms are free running meaning that their period is 
slightly greater than 24 hours (Toh, 2008). Circadian rhythms are important in various cycles 
including sleep/wakefulness, endocrine signaling, body temperature, and feeding/fasting cycles 
among many others. 
Light acts as the most potent zeitgeber by entraining circadian rhythms to the 24 hour 
day. Light entrains the SCN through excitatory signaling through the retinohypothalamic tract 
(Plano et al., 2017). External light cues are received through this tract and in turn result in 
upregulation of clock genes important in resetting the internal clock. The effects of altered 
lighting conditions in mice can have the following effects (i) dim light at night (DLAN) causes 
increased day time activity and feeding, blunting of oscillating SCN clock genes and insulin 
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sensitivity (ii) LL causes arrhythmic activity, loss of feeding rhythm, blunting of oscillating SCN 
clock genes and insulin sensitivity (iii) simulated jet-lag causes sporadic activity, disrupted feeding 
behavior, two altered oscillation SCN clock gene rhythms, and blunted insulin sensitivity and all 
three altered light conditions result in increased body mass (reviewed by Plano et al., 2017). Thus, 
light conditions play an essential role on circadian rhythms at the behavioral, biochemical, and 
metabolic level. 
Although the SCN syncs and couples to peripheral tissues, there are cases in which 
peripheral rhythms can be out of sync from the SCN due to other external cues or peripheral 
tissues adapting slowly in comparison to the SCN (Fonken & Nelson, 2014). For example in 
simulated-jet lag light exposure, the SCN clock genes have two oscillations: a cycle entrained prior 
to the jet-lag and a shifted cycle with the peak occurring later with the same amplitude. This 
rhythm is opposite to the liver tissue clock gene oscillations that have an out of phase cycle (Plano 
et al., 2017). Opposing rhythms could be influenced by additional external cues such as food 
availability and locomotor activity (Fonken & Nelson, 2014). Restricted feeding can result in 
anticipatory wakefulness and increases in locomotor activity and entrains circadian rhythms in 
the liver (Fonken & Nelson, 2014). This provides evidence on how internal clock mechanisms not 
only affect internal rhythms but how external cues can in turn affect the internal clock. 
Circadian Disruption and Metabolism 
In present day, urbanization is leading to increased light pollution that can in turn affect 
human circadian rhythms and health. With 70% of the U.S. being overweight or obese, it is an 
interesting question to investigate whether increased amount of light could be contributing to 
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this multifaceted problem (Levine, 2011). Further, light pollution is not the only form of circadian 
disruption affecting humans; shift workers, routine business travelers, and the use of technology 
at night are all forms of altered lighting conditions that can alter circadian rhythms. Natural 
compared to artificial lighting can also affect endogenous rhythms as it has been shown that 
humans exposed to natural lighting compared to electrical light had less variable melatonin and 
sleep rhythms (Fonken & Nelson, 2014). Human studies have found that altered lighting 
conditions can have adverse impacts on metabolism. Shift workers have been found to be at a 
higher risk for Metabolic Disorder and have increased body mass index (BMI) (Fonken & Nelson, 
2014) and social jetlag has been found to be correlated with metabolic issues and being 
overweight in individuals with non-communicable chronic diseases (Mota et al. 2017). These 
studies among many others are a part of a growing body of evidence suggesting circadian 
disruption from external light cues can be detrimental to human health. 
Studies in humans show that circadian disruption causes metabolic problems by (i) 
altering metabolic hormone levels such leptin and thyroid-stimulating hormones (Zimberg, et al 
2012); (ii) increasing glucose and insulin levels, conditions commonly found in patients with 
T2DM (Zimberg, et al., 2012); and (iii) that sleep restrictions lead to increased weight gain and 
increased caloric intake, especially during evening or “non-active” hours (Spaeth, et al., 2013). To 
this end in mice, if food availability is constrained to only the active part of the daily cycle, the 
increased obesity and diabetic phenotypes are negated (Hatori et al., 2012). In addition to 
circadian disruption affecting metabolism, altered metabolism such as that seen in obese 
individuals can in turn affect internal hormonal rhythms and body temperature (Fonken & 
Nelson, 2014).  
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Mice make great research subjects since they share circadian clock mechanisms and can 
develop metabolic disorders similar to humans. Hence, mouse-based models have been used to 
further investigate how circadian disruption leads to metabolic disorders. In mice, varying 
photoperiods with clear implications in humans are used such as the light cycles previously 
mentioned: simulated jetlag, DLAN and LL. The latter two simulate human activities from electric 
light pollution like watching TV and using smartphones throughout the night.  
Rodent studies provide models that can further be manipulated to have a greater 
understanding as to how circadian disruption leads to metabolic disorders and weight gain. It has 
been found that mice exposed to circadian disruptions such as LL, simulated jetlag, or a 20 hour 
LD day exhibit increased weight gain and symptoms of T2DM and Metabolic Syndrome (Fonken, 
et al 2010; Fonken et al., 2013; Karatsoreos et al., 2010). Several factors have been found to 
potentially contribute to the obesogenic effects of circadian disruption. These factors include 
disruption of molecular clock rhythms, disruption of hormonal signaling involved in metabolism, 
alterations in sleep patterns, and alterations in feeding behavior.  
Disruption of Molecular Clock Rhythms 
Through the use of genetic manipulations core clock genes such as CLOCK and BMAL1 
have been altered to study the consequences of mutated molecular clock genes on metabolism. 
In CLOCK/BMAL1 mutants, it was found that glucose metabolism and insulin signaling have 
disrupted cycles, reduced insulin secretion and, impaired glucose tolerance (Huang et al., 2011). 
A conditional CLOCK mutant with no expression in the liver and skeletal muscle had reduced 
insulin and impaired glucose tolerance as well suggesting peripheral tissues rhythms may play an 
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important role in energy homeostasis (Kennaway et al., 2007).  DLAN was found to cause 
increased weight gain despite similar food intake suggesting that peripheral tissues internal 
rhythm are needed for metabolic regulation (Borniger et al., 2014). Interestingly, time restricted 
sleeping in wildtype mice showed hallmarks of obesity such as increased food intake and leptin 
resistance however in Per 1/2 double mutants these obesogenic effects were blunted protecting 
the mice (Husse et al., 2012). Together these findings suggest that core clock genes in both the 
SCN and peripheral tissues are important in maintaining metabolic rhythms and targeting of 
particular molecular clock components such as Per 1/2 can protect against obesogenic effects. 
Disruption of Hormonal Signaling 
Alterations in molecular clock rhythms can dysregulate hormones that rely on this 
mechanism as a pacemaker. This includes metabolically related hormones such as insulin, leptin, 
and ghrelin. It has been found that there are alterations of endocrine hormone secretion in clock 
mutant mice (Fonken & Nelson, 2014). A disrupted 20 hour LD cycle resulted in increased insulin 
and leptin compared to LD control (Karatsoreos et al., 2011). In BMAL1-knockout mice, insulin 
secretion loses rhythmicity (Shi et al., 2013). Leptin and Ghrelin rhythms are also affected in 
BMAL1 mutants (Tsang et al., 2017). Ablation of the SCN causes loss of leptin rhythms showing 
that circadian rhythms and metabolic signaling are interconnected (Froy, 2010). Previously, it was 
found that in a LL cycle mice exhibit symptoms of hyperthyroidism in which thyroid stimulating 
hormone (TSH) was decreased and free thyroid hormone was increased along with abolishment 




Alterations in Sleep Patterns 
Changes to sleep patterns can also contribute to the metabolic problems associated with 
circadian disruption. In two studies it was found that fragmented sleep can cause increased food 
intake and glucose intolerance in one study and increased caloric intake and increased leptin in 
the second (Baud et al., 2012; Wang et al., 2014). Sleep changes seem to be able to occur as a 
result of obesity as well as it was found that a mouse model of obesity exhibited increase in 
fragmented sleeping, weakened rhythmicity during REM sleep, and an increase in overall sleep 
(Laposky et al., 2008).  
Alterations in Feeding Behavior 
This study is particularly interested in feeding behaviors and how manipulating the 
temporal point in which they occur could be beneficial against the adverse effects of circadian 
disruption. Circadian disruption causes altered feeding due to disrupted sleep/wake behaviors 
that in turn lead to eating at different times. DLAN exposure in mice has been found to cause 
increased daytime activity in nocturnal mice (Shuboni & Yan, 2010). Circadian disruption leads to 
higher caloric intake due to consumption during their inactive period (day). This combination of 
higher caloric intake, plus de-synchrony between overt behavior and internal physiology of an 
individual, can result in a net positive energy balance and subsequent weight gain (Zimberg, et al 
2012). Interestingly, increases in obesity are prevented when mice experiencing circadian 
misalignment are restricted food during their active phase (nighttime as mice are nocturnal)  
(Oike, et al 2015). Thus, the temporal point at which food consumption occurs is potentially a 




One potential connection between circadian function and eating behaviors is the 
Neuropeptide Y (NPY)/Peptide YY (PYY) system. PYY exists in two forms, PYY1-36 (untruncated 
form) and PYY3-36 (truncated form), which are both secreted from the hind gut; PYY1-36 dominates 
when a mammal is fasted and PYY3-36 dominates after feeding (Ballatyne, 2006; De Silva & Bloom, 
2012). After secretion, circulating PYY crosses the blood brain barrier and binds to metabotropic 
receptors in the arcuate nucleus (ARC) of the hypothalamus of which there are four receptor 
types Y1, Y2, Y4, and Y5 (Ballatyne, 2006). PYY1-36 is nondiscriminatory as it binds to all 4 receptor 
types in the ARC and promotes food intake along with another agonist NPY. During the time of 
food intake however, PYY3-36 secretion increases in addition to the enzyme dipeptidyl peptidase 
IV (DPP-IV) cleaving circulating PYY1-36 to PYY3-36 changing its activity to selectively binding to the 
inhibitory Y2 causing a decrease in appetite (Figure 1) (Michel et al., 2008; Zac-Varghese, et al 
Figure 1. PYY secretion and subsequent binding. Both forms of PYY is secreted from 
the hindgut and PYY1-36 is truncated by DDP-IV which changes it to PYY3-36 the form 
that selectively binds to the Y2 appetite inhibiting receptors in the ARC. 
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2010). While DPP-IV alters binding of PYY causing decreases in food intake, it inhibits other 
peptides like glucagon-like peptide-1 (GLP-1) which increases insulin levels to decrease blood 
sugar levels in response to feeding (Pala et al., 2003). 
Previous studies show that inactivation of Y2 receptors in mice led to increased food 
intake, body mass, and fat deposit (Naveilhan, et al 1999). This implies that, specifically PYY3-36 
the form specific to the Y2 receptor, seems to be a potent regulator of food consumption and 
metabolism. Further, when PYY3-36  was administered in humans food intake decreased whereas 
PYY1-36 when administered did not have an effect on energy intake and food consumption 
suggesting that PYY3-36 has greater potency in regulating food consumption compared to its full 
form counterpart (Sloth et al., 2006).  
The PYY/NPY system seems to be linked to circadian rhythms as NPY has been found to 
be a potent cue to reset the circadian clock (Maywood, et al 2002). However, more research is 
required to understand the relation between PYY and circadian rhythms. Interestingly, the phase 
advancing characteristics of NPY have been found to be mediated by the Y2 receptor, the same 
receptor PYY3-36 binds (Huhman, et al 1996). Further, nocturnal intraperitoneal injections of PYY3-
36 caused decreased wakefulness in rats (Akanmu et al., 2006). This implies a potential connection 
between PYY, food consumption, and circadian rhythm that my research aims to understand. 
Experimental Rationale 
This study conducted three separate experiments aimed at understanding if either forms 
of PYY is regulated in a cyclic manner and if PYY3-36 injections during the active (i.e., dark) periods 
could alleviate the negative metabolic symptoms of circadian disruption. Both studies utilized 
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CD1 mice as this strain has been previously found to have negative metabolic consequences 
when exposed to circadian disruption. DLAN caused blunting rhythms of the clock gene Per, 
increased daytime activity and altered light responsiveness; LL caused a decrease in thyroid 
stimulating hormone (TSH), increased free T4, and abolished day-night variation in leptin 
indicating that light entrainment is important for physiological rhythms within this strain (Fonken 
& Nelson 2014; Maroni et al. 2018).  
Experiment 1 exposed CD1 mice to 12:12 LD cycle and sacrificed animals at one of the 
four zeitgeber times ZT 0, ZT 6, ZT 12, and ZT 18. In experiment 2, mice were exposed to LD and 
injected with vehicle or PYY3-36 during one of the four zeitgeber times ZT 0, ZT 6, ZT 12, or ZT 18. 
Experiment 3 exposed CD1 mice to either a 12:12 LD cycle or LL. Both experiment 2 and 
experiment 3 groups were paired with either a PYY3-36 or vehicle (control) injection during their 
set injection which varied for experiment 2 but was set at the onset of their active period ZT 12 
for experiment 3 (Figure 2). Constant light was used specifically because unlike circadian 
disruptions such as DLAN and content darkness, constant light results in locomotor arrhythmicity 
and blunting of body temperature and glucocorticoid rhythms, a metabolically involved hormone 
(Fonken & Nelson, 2014).  
It was hypothesized that there are endogenous rhythms of both forms of PYY as they are 
involved in regulating food intake which is a rhythmic behavior itself. In addition, it was 
hypothesized that the decreased levels of PYY3-36 during the active period would make the ZT 12 
and ZT 18 time points have increased efficacy in inhibiting food intake as endogenous levels are 
lower during these times. In experiment 3, it was hypothesized that the external light output in 
LL could lead to downstream signaling that dysregulates peripheral tissue rhythms into 
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outputting hormones as if the mouse is always in its inactive period. Thus causing PYY3-36 
injections to be less effective at inhibiting food intake in LL due to the external light cues causing 
an increase in endogenous PYY3-36 levels to rise. 
Methods: 
Experiment 1 – Endogenous Levels of PYY 
Twenty-four male CD1 mice were purchased from Charles River Laboratories at 
(Shrewsbury, MA) approximately 7 weeks of age and were housed individually. After arrival, all 
animals were placed in a 12:12 LD cycle at 22˚C under 100 lux lighting with water ad libitum and 
Lab Diet 5001 rodent chow. Mice were maintained in these conditions for 1 month and then 
separated by time of day in which they would be sacrificed (ZT 0, ZT 6, ZT 12, or ZT 18). There 
were four groups: (1) ZT0 (n=6), (2) ZT 12 (n=6), (3) ZT 12 (n=6), (4) ZT 18 (n=6). Within each 
group, mice were fasted 12 hours prior to their scheduled sac time and whole blood was collected 
and allowed to clot. Serum was obtained by centrifugation at 4˚C for 20 minutes at 2000 g, 
aliquoted into microcentrifuge tubes, and stored in−80˚C. 
Statistical analyses  
One-way ANOVA (sac time) was used to uncover differences in endogenous PYY1-36, PYY3-






Experiment 2 – Physiological effects of PYY 
Animals and Injections 
This study had the approval of Bridgewater State University’s Institutional Animal Care 
and Use Committee. Forty-eight male CD1 mice were purchased from Charles River Laboratories 
at (Shrewsbury, MA) approximately 7 weeks of age and were housed individually. After arrival, 
all animals were placed in a 12:12 LD cycle at 22˚C under 100 lux lighting with water ad libitum 
and Lab Diet 5001 rodent chow. Mice were maintained in these conditions for 1 month and then 
placed into groups either receiving an injection of 1x PBS (control) or a 1 µg/10g PYY3-36 (from a 
1% PYY3-36 solution (w/v) in 1x PBS) intraperitoneal injection after a 12-hour fast and further 
separated by time of day (ZT 0, ZT 6, ZT 12, or ZT 18), in a 2 × 4 study setup. Thus, there were 
eight groups: (1) ZT 0/PBS (n = 6), (2) ZT 0/ PYY3-36 (n = 6), (3) ZT 6/PBS (n = 6), (4) ZT 6/ PYY3-36 (n 
= 6), (5) ZT 12/PBS (n = 6), (6) ZT 12/ PYY3-36 (n = 6), (7) ZT 18/PBS (n = 6), (8) ZT 18/ PYY3-36 (n = 
6). In this experimental set up animals were only handled for the following experiments during 
the time point they were assigned; i.e. ZT 0, ZT 6, ZT 12, or ZT 18. 
Food Consumption Protocol 
 Within each injection group, mice were fasted 12 hours prior to their scheduled injection 
time. Mice were injected at their set ZT group and then give 20g of food. Six hours after their 
injection time, food was weighed and food consumption was calculated (20g – post 6 hour food 




Fasting Glucose and Hormonal 
Assays 
Fasting glucose levels were 
measured after a 12-hour fast and 
were measured using a One-Touch 
Ultra-2 Glucose Monitor. Six hours 
after intraperitoneal injection, 
glucose levels were collected again 
and whole blood was collected at 
the aforementioned circadian time 
points and allowed to clot. Serum 
was obtained by centrifugation at 
4˚C for 20 minutes at 2000 g, 
aliquoted into microcentrifuge tubes, and stored in−80˚C. Levels of PYY1-36 (EIAM-PTT, Ray 
Biotech, Norcross, GA), PYY3-36 (EK-059-04, Phoenix Pharmaceuticals Inc., Burlingame, CA), and 
Insulin (90080, Crystal Chem, Elk Grove Village, IL) were measured using their respective ELISA 
kits. 
Statistical analyses  
Two-way ANOVAs (injection time and injection type) were utilized to uncover differences 
in PYY3-36 post-injection, insulin, food consumption, and weight change. 
 
Figure 2. Injection and food consumption protocol. Mice 
were fasted for 12 hours prior to their ZT injection time, 
injected at their assigned ZT time, given food, and measured 
for food consumption 6 hours after and sacrificed.   
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Experiment 3 – Effects of constant light on PYY food inhibition 
Animals and Injections 
Forty-eight male CD1 mice were purchased from Charles River Laboratories (Shrewsbury, 
MA) approximately 4 weeks of age and were housed individually. Circadian activity in cages were 
monitored using IR-beams (StarrLife Sciences, Oakmont, PA), as previously described 
(Nascimento et al. 2016b). After arrival, all animals were placed in a 12:12 LD cycle at 22 ºC under 
100 lux lighting with water ad libitum and Lab Diet 5001 rodent chow. After 1-week entrainment 
and acclimation, 24 mice were placed into constant light (LL) for 10 or 20 weeks (varying times 
are due to receiving 20 mice 10 weeks prior to the remaining 28 mice), while the remaining were 
kept under the 12:12 LD cycle. Mice were then separated into groups either receiving an injection 
of 1x PBS (control) or a 1 µg/10g PYY3-36 (from a 1% PYY3-36 solution (w/v) in 1x PBS) 
intraperitoneal injection after a 12-hour fast and further separated by light cycle, in a 2 × 2 study 
setup. Thus, there were four groups: (1) LL/PBS (n = 12), (2) LL/ PYY3-36 (n = 12), (3) LD/PBS (n = 
12), (4) LD/ PYY3-36 (n = 12). We chose to conduct this experiment at ZT 12 due to the finding that 
it lead to the largest difference in food consumption patterns (see results Experiment 2) and to 
determine whether LL exposure affects PYY3-36 efficacy. The food consumption effects of PYY3-36 
in LL were conducted in the same manner as in Experiment 2.  
Statistical analysis  






This study first wanted to understand the circulating levels of both PYY forms at four 
different time points throughout a 24-hour day. Endogenous PYY1-36 levels did not differ 
throughout the four times they were measured, ZT 0, ZT 6, ZT 12, or ZT 18 (Figure 3A). 
Endogenous PYY3-36 levels at ZT 6 were increased compared to ZT 12 and ZT 18 (Figure 3B, p < 
0.05).  
Fasting glucose levels in mice prior to a vehicle or PYY3-36 injection were significantly 
higher at ZT 0, the onset of their inactive period, compared to ZT 18, halfway through their active 
period (Figure 4A, p < 0.05). Regardless of injection group, there was a greater difference in 
glucose levels post-injection in the ZT 18 injected group compared to the ZT 6 and ZT 0 injected 
groups. Further in ZT 0 injected groups, vehicle injected groups had a greater glucose difference 
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Figure 3. Endogenous PYY
3-36
 levels has day/night variations but PYY
1-36
 does not in CD1 
mice. A) PYY
1-36 
levels are not significantly different throughout the day (n = 6). B) PYY
3-36 
levels are increased during their inactive period and are significantly decreased during their 
active period (n = 6). * indicates p<0.05 ZT difference within injection group.  
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after food consumption whereas PYY3-36 injected mice at ZT 0 had nearly no difference (Figure 
4B, p < 0.05). Insulin levels were decreased in PYY3-36 injected mice compared to vehicle injected 
mice regardless of the time of injection (Figure 4C, p < 0.05). Levels of PYY3-36 after injections 
Injection Time to Measurement Time
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* (vehicle only) 
Figure 4. Injections of PYY
3-36
 alters insulin levels and PYY
3-36 
at ZT 12 in CD1 mice. A) Fasting 
glucose levels in mice with no injections are highest during the onset of their inactive period 
and they decrease throughout the rest of their cycle (n = 12). B) PYY
3-36 
injected and vehicle 
mice had higher glucose levels after food consumption during their active period compared to 
their inactive period (n = 6). C) Insulin levels were significantly decreased in PYY
3-36 
injected 
mice (n = 6). D) PYY
3-36 
levels were higher during the active period in PYY
3-36
 injected mice 
compared to vehicle mice (n = 6). * indicates p<0.05 ZT difference within injection group. ┼ 
indicates p<0.05 PYY
3-36







were increased in the PYY3-36 injected group compared to vehicle only at ZT 12. PYY3-36 levels were 
increased in the vehicle injected animals at ZT 12 compared to ZT 18 (Figure 4D, p < 0.05). 
PYY3-36 injected mice consumed less food than vehicle control mice during all time periods 
except for the ZT 0 injected group. Additionally, the vehicle injected ZT 12 group consumed more 
compared to the ZT 0 vehicle injected group (Figure 5A, p < 0.05). PYY3-36 injected mice had 
decreased body mass compared to vehicle injected mice during the ZT 18 time point. Vehicle 
injected mice had increased body mass at ZT 18 compared to the ZT 6 time point (Figure 5B, p < 
0.05).  
PYY3-36 injected mice consumed less food than the vehicle injected mice within their 
respective photoperiods (Figure 6, p < 0.05). Further, it was found that food consumption was 
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* (vehicle only) 
Figure 5. PYY3-36 is Efficacious at Reducing Food consumption and body mass at ZT 12 in CD1 
mice. A) PYY
3-36
 injected mice consumed less than vehicle during all time periods except the 
ZT 0 injected group. The vehicle mice consumed more during their active period (n = 6). B) 
PYY
3-36
 injected mice lost the most body mass during their active period at ZT 18 whereas 
vehicle injected mice lost the most body mass during their inactive period at ZT 6. PYY
3-36
 
injected mice lost significantly more during ZT 18 compared to vehicle (n = 6). * indicates 
p<0.05 ZT difference within injection group. ┼ indicates p<0.05 PYY
3-36
 vs. vehicle group. 
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higher in the LD photoperiod compared to the LL in vehicle injected mice. There was no body 
mass increase in mice in LL (data not shown). 
Discussion: 
PYY3-36 has an Endogenous Rhythm 
Due to the lack of variation found in levels in PYY1-36, it suggests that the untruncated form 
does not have endogenous rhythmicity (Figure 3A). This is opposite of the truncated PYY3-36 as it 
was found to be increased halfway through the mice inactive period compared to both active 
period temporal points (Figure 3B). PYY1-36 shows high binding affinity to all four Y receptors 
found within the ARC whereas PYY3-36 shows high affinity specifically in the Y2 receptor 
(Ballantyne, 2006). This finding along with previous studies that have shown that NPY has already 





































PYY  * (vehicle only) ┼ 
Figure 6. Food consumption is altered by photoperiod in vehicle injected but not 
PYY3-36 injected mice. PYY3-36 injected consumed less than vehicle within its 
respective light of LD or LL. Vehicle LD consumed more than Vehicle LL (n = 12).* 
indicates p<0.05 photoperiod difference within injection group. ┼ indicates 
p<0.05 PYY
3-36
 vs. vehicle group. 
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receptor is specifically important in PYY/NPY rhythmicity. Further this endogenous rhythm of 
PYY3-36, the form that has been found to reduce food intake, follows with the logic that feeding 
should be occurring during active periods. If this rhythm were to be disrupted and feeding 
occurred during the inactive period this could lead to the weight gain correlated with circadian 
disruption. 
Exogenous PYY3-36 Alters Insulin Production, Glucose, and PYY3-36 Levels 
Fasting glucose levels were increased during the onset of the inactive period ZT 0 
compared to halfway through the active period ZT18 (Figure 4A). Insulin is normally secreted in 
response to increased circulating glucose levels which occurs after food intake and food intake 
generally occurs during the active phase (Night ZT 12/ZT 18). Despite a lack of food intake, this 
difference in glucose levels could be attributed to insulin sustaining its day/night variation. This 
variation results in processing of glucose during the active period of ZT 18 but a lack of processing 
during the inactive period ZT 0 resulting in the difference in glucose levels. 
Decreased insulin levels in PYY3-36 injected mice aligns with previous studies in which it 
was found that PYY3-36 injections result in decreased insulin levels (Figure 4C; Böttcher et al., 
1989). It has also been found that insulin levels are increased in PYY-knockout mice (Boey et al., 
2006). Since PYY3-36 reduces food intake, circulating glucose levels will begin to reduce as well 
having there be less need for circulating insulin to process available glucose. Further, DPP-IV 
inactivates GLP-1 decreasing insulin secretion while activating appetite suppressing PYY3-36 (Pala 
et al., 2003). Therefore, these results follow with the expected outcomes in the current metabolic 
point the mice are at.  
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Despite all temporal points being injected with PYY3-36 there was only a significant 
difference in the PYY3-36 injected versus control during the ZT 18 measurement time (Figure 4D). 
This could be due to the low PYY3-36 levels endogenously expressed at ZT 18 (Figure 3B) however, 
PYY3-36 levels were also low during ZT 12 in which no differences in PYY3-36 injected versus control 
were found. The absence of difference in the other three temporal points ZT 0, ZT 6, and ZT 12 is 
likely because PYY3-36 only has a half-life of 8 minutes so the increase in exogenous PYY3-36 likely 
tapers off to basal levels by 6 hours post injection (De Silva & Bloom, 2012). 
The Timing of PYY Injections Affects its Efficacy 
Surprisingly, the only body mass difference between PYY3-36 versus control was at the ZT 
18 injection group which was not the injection time with the greatest food consumption 
difference in PYY3-36 injected versus control however, there was still a significant difference in 
food consumption in the PYY3-36 compared to the vehicle control at this time (Figure 5A, 5B). As 
expected, PYY3-36 reduced food intake, but our results also indicate that it is most effective during 
the beginning of the night, the same time that food restriction is efficacious in alleviating obesity 
and T2DM symptoms. A study in monkeys found a similar result in which PYY3-36 injections were 
only able to inhibit food intake during the day time (active period) but not the night time (inactive 
period) (Koegler et al., 2005). This alteration in efficacy could be due to the lower levels during 
an animal’s active period. These lower circulating levels of PYY3-36 could mean that injections can 
have a greater effect compared to when levels are high during the animals’ inactive period. PYY3-
36 may competitively bind to the Y2 receptor causing anorexigenic signaling compared to other 
Y2 agonists NPY and PYY1-36. Further, vehicle injected animals consumed significantly more during 
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their active period ZT 18 compared to the onset of their inactive period ZT 0 which follows with 
the fasting glucose data previously found (Figure 4A).  
PYY Efficacy is not Affected by LL 
 PYY3-36 reduced food intake regardless of the cycle suggesting that photic cues did not 
result in an increased secretion of PYY3-36 due to the constant external photic cues (Figure 6). 
However, this cannot be confirmed until concentration of PYY3-36 is quantified. Surprisingly in this 
study, there were no significant differences in body mass (data not shown). A study previously 
found that CD1 strain exhibits hyper locomotion when exposed to altered light which could 
explain the lack of body mass increase in LL mice and additionally LL conditions can cause 
symptoms of hyper thyroidism which results in weight loss (McGowan & Coogan, 2013; Maroni 
et al. 2018). As explained previously, LL affects activity and various metabolic hormones. So this 
raises the question as to how PYY3-36 was still able to effectively inhibit food intake when the 
internal rhythms of both the SCN and peripheral tissues are likely out of phase. One explanation 
could have to do with the PYY3-36 levels being blunted overall. In experiment 2, it was found that 
PYY3-36 injections were able to significantly reduce food intake at ZT 6, ZT 12, and ZT 18 being 
most effective when the endogenous levels were the lowest. This finding paired with experiment 
3 could mean that instead of the external photic cues causing increased PYY3-36 secretion or out 
of phase rhythms it could be causing blunting of the PYY3-36 making it effective at all time points. 
To answer this hypothesis, PYY3-36 injection efficacy would need to be tested at all time points 
like in experiment 2.  
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The finding that there was increased food consumption in vehicle injected mice during LD 
compared to LL is of interest. This finding supports previous studies where circadian disruption 
can alter feeding however it did not increase food intake. The decreased food consumption 
during ZT 12 in the LL vehicle injected mice could be indicating that there may be increased 
anorexigenic signals like PYY3-36 and leptin however this does not align with the the finding that 
PYY3-36 was effective at reducing food intake at this time. The decreased feeding in the vehicle LL 
mice could mean that feeding times are shifted to a different ZT as well and due to their 
unpredictable arrhythmic behavior the vehicle mice happened to be tested at a time point that 
they were inactive and not eating as much. Monitoring the feeding behaviors of CD1 mice 
exposed to constant light would be needed to understand if testing them at an inactive time 
caused the reduced food intake in vehicle LL mice. 
Conclusions 
Overall, this study provides evidence that PYY3-36 has an endogenous rhythm and although 
it reduces food intake when injected at ZT 6, ZT 12, and ZT 18 it is most efficacious at ZT 12. The 
effectiveness of PYY3-36 in LL could mean that it could potentially be used to inhibit food intake 
and reduce weight gain in circadian disrupted individuals. Endogenous PYY3-36 and insulin levels 
in experiment 3 are still needed to have a better understanding of the cause behind different 
food consumption in the vehicle LD versus vehicle LL but not the PYY3-36 LD versus PYY3-36 LL. This 
research underscores the importance of an individual’s circadian clock and how circadian 
disruption relates to food consumption.  This will also give a better understanding of PYY3-36 and 
the timing of food consumption and their potential to alleviate metabolic problems caused by 
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